Navigation Links
UF researcher describes new 5-million-year-old saber-toothed cat from Florida
Date:3/14/2013

, Hulbert said. The genus name Rhizosmilodon, meaning "root of Smilodon," implies the animal could be a missing link and direct ancestor of Smilodon, which became extinct about 11,000 years ago.

The study's lead author, Steven Wallace, an associate professor in the department of geosciences and member of the Don Sundquist Center of Excellence in Paleontology at East Tennessee State University, used comparative analysis of saber-toothed cat anatomy to help determine the animal's taxonomy. The analysis was primarily based on structure of the animal's lower jaw and teeth, smaller than the Smilodon and about the size of a modern Florida panther.

"The taxonomy of this animal was controversial because when it was first published 20 years ago, they only had one partial, somewhat-decent lower jaw, and it was missing some of the critical features," Hulbert said. "We now have more complete specimens showing it has a mixture of primitive and advanced characters, and does not match any previously named saber-toothed cat genus or species."

Originally misidentified as a member of the genus Megantereon in the early 1980s, Rhizosmilodon is instead the sister taxon to Megantereon and Smilodon, and the oldest of the group. These three cats are in the same tribe -- meaning they are more closely related than a family or subfamily -- and are often called as saber-toothed cats because of their long canine teeth, Hulbert said.

"When people think of saber-toothed cats, they think of it as just one thing, as if the famous tar pit saber-toothed cat was the only species, when in fact, it was an almost worldwide radiation of cats that lasted over 10 million years and probably had a total of about 20 valid species," Hulbert said. "Counting the newly described animal, there are now six different species of saber-toothed cats known just from Florida."

Saber-toothed cat expert Julie Meachen, an in
'/>"/>

Contact: Richard Hulbert
rhulbert@flmnh.ufl.edu
352-273-1821
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers divide enzyme to conquer genetic puzzle
2. Researchers building stronger, greener concrete with biofuel byproducts
3. Immune cells cluster and communicate like bees, researcher says
4. Fertilizers could help tackle nutritional deficiency in African country, researchers say
5. Stanford researchers map out an alternative energy future for New York
6. Asterixs Roman foes -- Researchers have a better idea of how cancer cells move and grow
7. Researchers find alternative cholesterol-lowering drug for patients who cant tolerate statins
8. Researchers develop tools for discovering new species
9. University of Illinois researchers develop AFM-IR for nanometer scale chemical identification
10. March of Dimes awards $250,000 to researcher who identified heart disease genes
11. Worlds leading lion researcher calls for a Marshall Plan for African wildlife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, reminds investors and media that  Mr. ...  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of nine ... Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... Through the generous support of the Breast ... Cancer Research (AACR) is pleased to announce the ... Translational Breast Cancer Research. These grants provide ... designed to accelerate the discovery, development, and application ...
... DC Some nanotechnology fanciers suggest that, like ... will flock or clump together. ... risks as nanotechnology manufacturing increases and the number ... nanoparticle expert Andrew Maynard, chief science advisor to ...
... A modified plastic material greatly improves the ability to ... the gas is prepared for use, according to engineers ... analyzed the new plastics performance. Like a sponge ... permits carbon dioxide or other small molecules to go ...
Cached Biology News:AACR, BCRF award inaugural grants in translational breast cancer research 2AACR, BCRF award inaugural grants in translational breast cancer research 3Nanoparticle exposures happen, says expert 2New membrane strips carbon dioxide from natural gas faster and better 2New membrane strips carbon dioxide from natural gas faster and better 3
(Date:6/2/2015)... Through rare discovery of new physics ... is enabling World Scientists to actually see, watch, ... displaying the full nature (position, shape, size, number) of ... Porter, Co-Founder of the Yancy Corporation, says, "Our rare ... They come once in a lifetime, if at all. ...
(Date:6/1/2015)... Chosen for his engaging style ... has been selected as keynote speaker for a ... will deliver his keynote: "Don't Stop Thinking About ... to the American Medical Association, Blue Cross Blue ... Forum on Wireless Healthcare, United Healthcare, IASIS Healthcare, ...
(Date:6/1/2015)... and RARITAN, N.J. ... Development, LLC (Janssen) announced data from the Phase ... improvement in progression-free survival (PFS) with trabectedin (YONDELIS ... advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated ... chemotherapy regimen. SAR3007 is the largest randomized Phase ...
(Date:6/1/2015)... , June 1, 2015  Novartis is highlighting ... of CTL019, an investigational chimeric antigen receptor (CAR) ... the treatment of specific types of hard-to-treat non-Hodgkin ... the University of Pennsylvania,s Perelman School of Medicine ... diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma ...
Breaking Biology Technology:Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6
... CRANBURY, N.J., Aug. 12 Palatin Technologies, Inc. (NYSE ... of a Phase 1 clinical trial of subcutaneously administered ... male erectile dysfunction (ED) and female sexual dysfunction (FSD). ... blood plasma levels can be obtained without blood pressure ...
... Health care jobs continue ... industry remains at 20,000 monthly, and health care has one of the the lowest unemployment rates ... feeling the economic pinch more and more. , ... (Vocus) August 12, 2009 -- There is a dichotomy between simultaneous job creation and job ...
... Scientists drew fittingly from Roman mythology when they named ... Janus, who is usually depicted as having two faces ... been fascinated by the tantalizing possibilities of these particles ... and many other devices. However, realizing these applications requires ...
Cached Biology Technology:Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 2Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 3Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration 4The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 2The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 3The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers 4Capping a two-faced particle gives duke engineers complete control 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Blue Standard is 3-cyano-7-hydroxycoumarin....
Biology Products: